Engineers Gate Manager’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,400
| Closed | -$692K | – | 2185 |
|
|
2025
Q2 | $692K | Sell |
5,400
-19,289
| -78% | -$2M | 0.01% | 1320 |
|
|
2025
Q1 | $2.19M | Sell |
24,689
-7,358
| -23% | -$718K | 0.04% | 654 |
|
|
2024
Q4 | $2.8M | Buy |
32,047
+17,489
| +120% | +$1.6M | 0.05% | 484 |
|
|
2024
Q3 | $1.35M | Buy |
14,558
+2,306
| +19% | +$229K | 0.03% | 831 |
|
|
2024
Q2 | $1.32M | Sell |
12,252
-5,417
| -31% | -$542K | 0.03% | 759 |
|
|
2024
Q1 | $1.68M | Buy |
17,669
+12,026
| +213% | +$1.03M | 0.04% | 553 |
|
|
2023
Q4 | $521K | Sell |
5,643
-4,520
| -44% | -$293K | 0.01% | 1156 |
|
|
2023
Q3 | $510K | Sell |
10,163
-2,819
| -22% | -$151K | 0.02% | 1051 |
|
|
2023
Q2 | $820K | Buy |
12,982
+6,815
| +111% | +$370K | 0.03% | 794 |
|
|
2023
Q1 | $277K | Sell |
6,167
-4,907
| -44% | -$221K | 0.01% | 1288 |
|
|
2022
Q4 | $485K | Sell |
11,074
-5,699
| -34% | -$273K | 0.03% | 915 |
|
|
2022
Q3 | $1.1M | Buy |
16,773
+9,355
| +126% | +$601K | 0.07% | 400 |
|
|
2022
Q2 | $375K | Buy |
7,418
+3,627
| +96% | +$212K | 0.01% | 1268 |
|
|
2022
Q1 | $242K | Buy |
+3,791
| New | +$272K | 0.01% | 1533 |
|
|
2021
Q2 | – | Sell |
-5,130
| Closed | -$499K | – | 1634 |
|
|
2021
Q1 | $499K | Buy |
5,130
+2,338
| +84% | +$233K | 0.02% | 991 |
|
|
2020
Q4 | $313K | Buy |
2,792
+99
| +4% | +$10.4K | 0.01% | 1271 |
|
|
2020
Q3 | $250K | Buy |
+2,693
| New | +$207K | 0.01% | 1337 |
|
|
2020
Q2 | – | Sell |
-15,671
| Closed | -$916K | – | 1704 |
|
|
2020
Q1 | $916K | Buy |
15,671
+7,761
| +98% | +$499K | 0.07% | 474 |
|
|
2019
Q4 | $634K | Buy |
+7,910
| New | +$592K | 0.03% | 870 |
|
Other funds holding BPMC
IA
HNB
Engineers Gate Manager's BPMC Position: Q3 2025 in Review
Engineers Gate Manager sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 5,400 shares — an estimated $692K sold.
Engineers Gate Manager first reported a position in BPMC in Q4 2019 and held it in 19 quarters. The position peaked at $2.8M in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Engineers Gate Manager reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Engineers Gate Manager sold 5,400 Blueprint Medicines shares in Q3 2025, an estimated $692K.
- Engineers Gate Manager first reported a position in Blueprint Medicines in Q4 2019 and held it in 19 quarters.
- Engineers Gate Manager's Blueprint Medicines position peaked at $2.8M in Q4 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.